Abstract
Traumatic brain injury, which is the leading cause of death in young adults and children, is associated with motor, mental and behavioral disabilities in many of its survivors [1]. To date, none of the drugs which had been successfully tested in animal models made a breakthrough in the treatment of head injured patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Waxweiler RJ, Thurman D, Sniezek J, Sosin D, O’Neil J (1995) Monitoring the impact of traumatic brain injury: a review and update. J Neurotrauma 12: 509–516
Rothwell NJ, Hopkins SJ (1995) Cytokines and the nervous system II: action and mechanisms of action. Trends Neurosci 18: 130–136
Merril JE, Benveniste EN (1996) Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 19: 331–338
Barger S (1998) Tumor necrosis factor, the good, the bad and the umbra. In: MP Mattson (ed): Neuroprotective signal transduction. Humana Press, Totowa, NJ, 163–183
Munoz-Fernandez M, Fresno M (1998) The role of tumor necrosis factor, interleukin-6, Interferon-y and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol 56: 307–340
Barone FC, Feuerstein, GZ (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 19: 819–834
Morganti-Kossman MC, Lenzlinger PM, Hans V, Stahel P, Csuka E, Ammann E, Stocker R, Trentz O, Kossmann T (1997) Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Mol Psych 2: 133–136
Gourin CG, Shackford SR (1997) Production of tumor necrosis factor-alpha and interleukin-1 beta by human cerebral microvascular endothelium after percussive trauma. J Trauma 42: 1101–1107
Feuerstein GZ, Wang X, Barone FC (1997) Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets. Ann NY Acad Sci 825: 179–193 (review)
Liu T, Clark RK, McDonnel PC, Toung PR, White RF, Barone FC, Feuerstein FZ (1994) Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25: 1481–1488
Taupin V, Toulmond S, Serrano A, Benavides J, Zavala F (1993) Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre-and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J Neuroimmunol 42: 177–185
Shohami E, Gallily R, Mechoulam R, Bass, Ben-Hur T (1997) Cytokine production in the brain following closed head injury: Dexanabinol (HU-211) is a novel TNFa inhibitor and an effective neuroprotectant. J Neuroimmunol 72: 169–177
Shohami E, Novikov M, Bass R, Yamin A, Gallily R (1994) Closed head injury triggers early production of TNF and IL-6 by brain tissue. J Cereb Blood Flow Metabol 14: 615–619
Fan L, Young PR, Barone FC, Feuerstein GZ, Smith DH, McIntosh TK (1996) Experimental brain injury induces differential expression of tumor necrosis factor-a mRNA in the CNS. Mol Br Res 36: 287–291
Kita T, Liu L, Tanaka N, Kinoshita Y (1997) The expression of tumor necrosis factor-alpha in the rat brain after fluid percussive injury. Int J Legal Med 110: 305–311
Kaltschmidt B, Sparna T, Kaltschmidt C (1999) Activation of NF-KB by reactive oxygen intermediates in nervous system. Antiox Redox Signal 1: 129–144
Grimaldi LM, Martino GV, Franciotta DM, Brustia R, Castagna A, Pristera R, Prizzarin A (1991) Elevated tumor necrosis factor-alpha levels in spinal fluid from HIV-1 infected patients with central nervous system involvement. Ann Neurol 29: 21–25
Leist TP, Frei K, Kam-Hansen S, Zinkernagel RM, Fontana A (1988) Tumor necrosis factor a in cerebrospinal fluid during bacterial, but not viral, meningitis: evaluation in murine model infections and in patients. J Exp Med 167: 1743–1758
Tracey KJ (1991) Tumor necrosis factor (cachectin) in the biology of septic shock syndrome. Circ Shock 35: 123–128
Jiang J, Tian K, Chen H, Zhu P, Wang Z (1997) Kinetics of plasma cytokines and its clinical significance in patients with severe trauma. Chin Med J 110: 923–926
Goodman JC, Robertson CS, Grossman RG, Narayan RK (1990) Elevation of tumor necrosis factor in head injury. J Neuroimmunol 30: 213–217
Ross SA, Halliday MI, Campbell GC, Byrnes DP, Rowlands BJ (1994) The presence of tumor necrosis factor in CSF and plasma after severe head injury. Br J Neurosurg 8: 419–425
Mathiesen T, Edner G, Ulfarsson E, Andersson B (1997) Cerebrospinal fluid interleukin1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg 87: 215–220
Buttini M, Mir A, Appel K, Wiederhold KH, Limonta S, Gebicke-Haerter PJ, Boddeke HW (1997) Lipopolysaccharide induces expression of tumor necrosis factor alpha in rat brain: inhibition by methylprednisolone and by rolipram. Br J Pharmacol 122: 1483–1489
Novogrodsky A, Vanichkin A, Patya M, Gazit A, Osherov N, Levitzki A (1994) Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264: 1319–1322
Bianchi M, Bloom O, Raabe T, Cohen PS, Chesney J, Sherry B, Schmidtmayerova H, Calandra T, Zhang X, Bukrinsky M et al (1996) Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J Exp Med 183: 927–936
Meistrell ME 3rd, Botchkina GI, Wang H, Di Santo E, Cockroft KM, Bloom O, Vishnubhakat JM, Ghezzi P, Tracey K (1997) Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia. Shock 8: 341–348
Nawashiro H, Martin D, Hallenbeck JM (1997) Inhibition of tumor necrosis factor ameliorated brain infarction in mice. J Cereb Blood Flow Metab 17: 229–232
Shohami E, Bass R, Wallach D, Yamin A, Gallily R (1996) Inhibition of tumor necrosis factor (TNFa) activity in rat brain is associated with cerebroprotection after closed head injury. J Cerebr Blood Flow Metab 16: 378–384
Leker R, Shohami E, Abramsky O, Ovadia H. (1999) Dexanabinol; a novel neuroprotective drug in experimental focal cerebral ischemia. J Neurol Sci 162: 114–119
Lavie G, Teichner A, Shohami E, Ovadia H, Leker RR (2001) Long term cerebropro-tective effects of dexanabinol in a model of focal cerebral ischemia. Brain Res 901: 195–201
Knoblach SM, Faden AI (1998) Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp Neurol 153: 143–151
Bethea JR, Nagashima H, Acosta MC, Briceno C, Gomez F, Marcillo AE, Loor K, Green J, Dietrich WD (1999) Systemically administered Interleukin-10 rescues tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 16: 851–863
Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW, Mattson MP (1996) Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med 2: 788–794
Sullivan PG, Bruce-Keller AJ, Rabchevsky AG, Christakos S, Clair DK, Mattson MP, Scheff SW (1999) Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J Neurosci 19: 6248–6256
Stahel PF, Shohami E, Younis FM, Kariya K, Otto VI, Lenzlinger PM, Grosjean MB, Eugster HP, Trentz O, Kossmann T et al (2000) Experimental closed head injury: Analysis of neurological outcome, blood brain barrier dysfunction, intracranial neutrophil infiltration and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J Cereb Blood Flood Metabol 20: 369–380
Stahel PF, Kariya K, Shohami E, Barnum SR, Eugster H, Trentz O, Kossmann T, Morganti-Kossmann MC (2000) Intracerebral complement C5a receptor (CD88) expression is regulated by TNF and lymphtoxin-a following closed head injury in mice. J Neuroimmunol 109:164–172
Osaka H, Mukherjee P, Aisen P, Pasinetti GM, (1999) Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity. J Cell Biochem 73: 303–311
Scherbel U, Raghupathi R, Nakamura M, Saatman KE, Trojanowski JQ, Neugebauer E, Marino MW, McIntosh TK (1999) Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc Natl Acad Sci USA 96: 8721–8726
Galasso JM, Wang P, Martin D, Silverstein FS (2000) Inhibition of TNFa can attenuate or exacerbate excitotoxic injury in neonatal rat barin. NeuroReport 11: 231–235
Phillips LM, Simon PJ, Lampson LA (1999) Site-specific immune regulation in the brain: differential modulation of major histocompatibility complex (MHC) proteins in brain-stem vs. hippocampus. J Comp Neurol 405: 322–333
Barger SW, Horster D, Furukawa K, Goodman Y, Krieglstein J, Mattson MP (1995) Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Nat Acad Sci USA 92: 9328–9332
Mattson MP, Cheng B, Baldwin SA, Smith-Swintosky VL, Keller J, Geddes JW, Scheff SW, Christakos S. (1995) Brain injury and tumor necrosis factors induce calbindin D-28k in astrocytes: evidence for a cytoprotective response. J Neur Res 42: 357–370
Chan PH, (1996) Role of oxidants in ischemic brain damage. Stroke 27: 1124–1129
Beit-Yannai E, Zhang R, Trembovler V, Samuni A, Shohami E (1996) Cerebroprotective effect of stable nitroxide radicals in closed head injury in the rat. Brain Res 717: 22–28
Beit-Yannai E, Kohen R, Horowitz M, Trembovler V, Shohami E (1997) Changes in biological reducing activity in rat brain following closed head injury: a cyclic voltammetry study in normal and acclimated rats. J Cereb Blood Flow Metabol 17: 273–279
Trembovler V, Beit-Yannai E, Younis F, Gallily R, Horowitz M, Shohami E (1999) Antioxidants attenuate acute toxicity of tumor necrosis factor a induced by brain injury in Rat. J Interferon Cytokine Res 19: 791–795
Ginis I, Hallenbeck JM, Liu J, Spatz M, Jaiswal R, Shohami E (2000) Tumor necrosis factor and reactive oxygen species cooperative cytotoxicity is mediated via inhibition of NF-KB. Mol Med 6: 1028–1041
Trembovler V, Abu-Raya S, Lazarovic P, Shohami E (2000) Toxic effects of tumor necrosis factor alpha are enhanced by reactive oxygen species. 5th Intl. Neurotrauma symposium, Garmisch, Germany (abstract)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Basel AG
About this chapter
Cite this chapter
Shohami, E. (2001). Biphasic activity of tumor necrosis factor in stroke and brain trauma: interaction with reactive oxygen species. In: Feuerstein, G.Z. (eds) Inflammation and Stroke. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8297-2_13
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8297-2_13
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9508-8
Online ISBN: 978-3-0348-8297-2
eBook Packages: Springer Book Archive